1h0g

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
==Overview==
==Overview==
-
Over the past years, family 18 chitinases have been validated as potential, targets for the design of drugs against human pathogens that contain or, interact with chitin during their normal life cycles. Thus far, only one, potent chitinase inhibitor has been described in detail, the, pseudotrisaccharide allosamidin. Recently, however, two potent, natural-product cyclopentapeptide chitinase inhibitors, argifin and, argadin, were reported. Here, we describe high-resolution crystal, structures that reveal the details of the interactions of these, cyclopeptides with a family 18 chitinase. The structures are examples of, complexes of a carbohydrate-processing enzyme with high-affinity, peptide-based inhibitors and show in detail how the peptide backbone and, side chains mimic the interactions of the enzyme with, chitooligosaccharides. Together with enzymological characterization, the, structures explain why argadin shows an order of magnitude stronger, inhibition than allosamidin, whereas argifin shows weaker inhibition. The, peptides bind to the chitinase in remarkably different ways, which may, explain the differences in inhibition constants. The two complexes provide, a basis for structure-based design of potent chitinase inhibitors, accessible by standard peptide chemistry.
+
Over the past years, family 18 chitinases have been validated as potential targets for the design of drugs against human pathogens that contain or interact with chitin during their normal life cycles. Thus far, only one potent chitinase inhibitor has been described in detail, the pseudotrisaccharide allosamidin. Recently, however, two potent natural-product cyclopentapeptide chitinase inhibitors, argifin and argadin, were reported. Here, we describe high-resolution crystal structures that reveal the details of the interactions of these cyclopeptides with a family 18 chitinase. The structures are examples of complexes of a carbohydrate-processing enzyme with high-affinity peptide-based inhibitors and show in detail how the peptide backbone and side chains mimic the interactions of the enzyme with chitooligosaccharides. Together with enzymological characterization, the structures explain why argadin shows an order of magnitude stronger inhibition than allosamidin, whereas argifin shows weaker inhibition. The peptides bind to the chitinase in remarkably different ways, which may explain the differences in inhibition constants. The two complexes provide a basis for structure-based design of potent chitinase inhibitors, accessible by standard peptide chemistry.
==About this Structure==
==About this Structure==
Line 14: Line 14:
[[Category: Protein complex]]
[[Category: Protein complex]]
[[Category: Serratia marcescens]]
[[Category: Serratia marcescens]]
-
[[Category: Aalten, D.M.F.Van.]]
+
[[Category: Aalten, D M.F Van.]]
[[Category: Arai, N.]]
[[Category: Arai, N.]]
-
[[Category: Eijsink, V.G.H.]]
+
[[Category: Eijsink, V G.H.]]
-
[[Category: Houston, D.R.]]
+
[[Category: Houston, D R.]]
[[Category: Omura, S.]]
[[Category: Omura, S.]]
-
[[Category: Peter, M.G.]]
+
[[Category: Peter, M G.]]
[[Category: Shiomi, K.]]
[[Category: Shiomi, K.]]
[[Category: Synstad, B.]]
[[Category: Synstad, B.]]
Line 30: Line 30:
[[Category: inhibitor]]
[[Category: inhibitor]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Feb 3 09:44:46 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 12:56:04 2008''

Revision as of 10:56, 21 February 2008


1h0g, resolution 2.00Å

Drag the structure with the mouse to rotate

COMPLEX OF A CHITINASE WITH THE NATURAL PRODUCT CYCLOPENTAPEPTIDE ARGADIN FROM CLONOSTACHYS

Overview

Over the past years, family 18 chitinases have been validated as potential targets for the design of drugs against human pathogens that contain or interact with chitin during their normal life cycles. Thus far, only one potent chitinase inhibitor has been described in detail, the pseudotrisaccharide allosamidin. Recently, however, two potent natural-product cyclopentapeptide chitinase inhibitors, argifin and argadin, were reported. Here, we describe high-resolution crystal structures that reveal the details of the interactions of these cyclopeptides with a family 18 chitinase. The structures are examples of complexes of a carbohydrate-processing enzyme with high-affinity peptide-based inhibitors and show in detail how the peptide backbone and side chains mimic the interactions of the enzyme with chitooligosaccharides. Together with enzymological characterization, the structures explain why argadin shows an order of magnitude stronger inhibition than allosamidin, whereas argifin shows weaker inhibition. The peptides bind to the chitinase in remarkably different ways, which may explain the differences in inhibition constants. The two complexes provide a basis for structure-based design of potent chitinase inhibitors, accessible by standard peptide chemistry.

About this Structure

1H0G is a Protein complex structure of sequences from Serratia marcescens with and as ligands. Active as Hydrolase, with EC number 3.2.1.14. Known structural/functional Site: . Full crystallographic information is available from OCA.

Reference

High-resolution structures of a chitinase complexed with natural product cyclopentapeptide inhibitors: mimicry of carbohydrate substrate., Houston DR, Shiomi K, Arai N, Omura S, Peter MG, Turberg A, Synstad B, Eijsink VG, van Aalten DM, Proc Natl Acad Sci U S A. 2002 Jul 9;99(14):9127-32. Epub 2002 Jul 1. PMID:12093900

Page seeded by OCA on Thu Feb 21 12:56:04 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools